Overland Park, KS, United States of America

Jeffery Hester

This inventor holds 1 USPTO granted patent. Top assignee: Pathology Watch Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffery Hester. Retrieved from https://idiyas.com/inventor/jeffery-hester

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffery Hester and Neural-Network-Based Melanoma Pathology

Introduction

Jeffery Hester is an inventor based in Overland Park, Kansas, and is associated with Pathology Watch Inc. His patent work focuses on applying neural networks to melanoma pathology by combining molecular and image data from a patient biopsy sample.

Latest Patents

Hester is named on one patent: “Systems, Methods, and Devices for Melanoma Pathology Using One or More Neural Networks.” The disclosed techniques describe encoding molecular data from a biopsy sample, analyzing corresponding image data with an image-analysis neural network, and combining the encoded molecular information with image data at an intermediate layer. The network then uses the combined information to produce a prognosis output. The patent describes additional features and examples of this approach.

Career Highlights

Hester’s listed patent activity centers on computational pathology and the use of neural networks to support melanoma prognosis. His work brings together molecular information and biopsy imagery within a single analytical process. He is associated with Pathology Watch Inc.

Collaborations

The provided information identifies Daniel Lambert and James Requa as Hester’s coworkers. Their specific roles in the patent or related work are not stated.

Conclusion

Jeffery Hester’s patent describes a neural-network approach that combines molecular and image data to generate prognosis outputs for melanoma pathology, reflecting an application of machine learning to biopsy analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…